Avita Medical (PINKSHEETS: AVMXY) (ASX: AVH) develops and distributes regenerative and tissue-engineered products to treat a broad range of wounds, scars, and skin defects. The company’s lead product, ReCell® Spray-On Skin®, is applicable to a wide variety of burns, plastic, reconstructive, and cosmetic procedures. ReCell is patented, CE-marked for Europe, TGA-registered in Australia, and SFDA-cleared in China. ReCell is not available for sale in the United States, but currently is an investigational device limited to investigational use. For more information visit the company’s Web site at www.avitamedical.com

B. Riley & Co. provides a full array of corporate finance, research, sales, trading, and otcqx dad services to corporate, institutional, and high net worth clients.  Headquartered in Los Angeles, with offices in San Francisco, New York, and Newport Beach, the firm is recognized for its distinguished equity research, merger and acquisitions advisory services, initial and secondary public offerings, and institutional private placements. For more information on B. Riley & Co., visit www.brileyco.com

Let us hear your thoughts below: